Costco’s decision to introduce discounted pricing on Ozempic and Wegovy marks a pivotal moment in both the U.S.

Motilal Oswal Financial Services has suggested BUY recommendation for Sun Pharmaceutical, targeting a 12-month price of Rs 1,960.

Prabhudas Lilladher has initiated a BUY call on Ajanta Pharma, urging investors to seize this opportunity based on the company’s robust branded generics (BGx) franchise, promising financial perform

Geojit Investments has issued an Accumulate rating on Granules India Limited, maintaining a revised target price of Rs 630, reflecting a potential upside of around 16% from the cur

MIT scientists have harnessed generative AI to revolutionize antibiotic discovery, unveiling two novel compounds capable of combating drug-resistant gonorrhoea and MRSA.

Kotak Institutional Equities has struck a bullish note on Piramal Pharma with its latest research, reiterating a BUY recommendation and projecting a fair value of Rs305 per share against a current